Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34892 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Xiaogan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospita…. Hauptthemen laut MEDLINE: DNA Repair, Germ-Line Mutation, Genetic Predisposition to Disease, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, Science Foundation of Peking University Cancer Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
The genetic predisposition to lymphoma is not fully understood. We identified 13 lymphoma‐cancer families (2011–2021), in which 27 individuals developed lymphomas and 26 individuals had cancers. Notably, male is the predominant gender in lymphoma patients, whereas female is the predominant gender in cancer patients ( p = .019; OR = 4.72, 95% CI, 1.30–14.33). We collected samples from 18 lymphoma patients, and detected germline variants through exome sequencing. We found that germline protein truncating variants (PTVs) were enriched in DNA repair and immune genes. Totally, we identified 31 heterozygous germline mutations (including 12 PTVs) of 25 DNA repair genes and 19 heterozygous germline variants (including 7 PTVs) of 14 immune genes. PTVs of ATM and PNKP were found in two families, respectively. We performed whole genome sequencing of diffuse large B cell lymphomas (DLBCLs), translocations at IGH locus and activation of oncogenes ( BCL6 and MYC ) were verified, and homologous recombination deficiency was detected. In DLBCLs with germline PTVs of ATM , deletion and insertion in CD58 were further revealed. Thus, in lymphoma‐cancer families, we identified germline defects of both DNA repair and immune genes in lymphoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Central Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
ORCID-Profile: Xiaogan Wang, Yuqin Song
Förderung
- Beijing Municipal Natural Science Foundation
- Science Foundation of Peking University Cancer Hospital
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Deng, L., Ping, L., Shi, Y., Wang, H., Feng, F., Leng, X., Tang, Y., Xie, Y., Ying, Z., Liu, W., Zhu, J., & Song, Y. (2024). Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families. International Journal of Cancer. https://doi.org/10.1002/ijc.34892
Vancouver
Wang X, Deng L, Ping L, Shi Y, Wang H, Feng F, et al. Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families. International Journal of Cancer. 2024. doi:10.1002/ijc.34892
BibTeX
@article{Wang2024,
author = {Wang, Xiaogan and Deng, Lijuan and Ping, Lingyan and Shi, Yunfei and Wang, Haojie and Feng, Feier and Leng, Xin and Tang, Yahan and Xie, Yan and Ying, Zhitao and Liu, Weiping and Zhu, Jun and Song, Yuqin},
title = {Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34892}
}
EUVIMED